trending Market Intelligence /marketintelligence/en/news-insights/trending/w_sj5cd9tnded_2awtqwlw2 content esgSubNav
In This List

HLS Therapeutics names CFO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


HLS Therapeutics names CFO

HLS Therapeutics Inc. appointed Tim Hendrickson as CFO, effective Sept. 6.

Hendrickson previously was the company's vice president of finance and administration, a position he has held since 2015.

Toronto-based HLS Therapeutics acquires and distributes in North American markets pharmaceutical products for the central nervous system and cardiovascular specialties.